# Teladoc Health (TDOC) — Analyst Forecast

TDOC · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/tdoc/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Hold | 5 | 19 | 0 | 24 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $7.50 | $8.33 | $10.00 | 3 |

Last price $5.97 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Aug 3, 2026 | Citigroup | Maintained | Neutral | $7.50 |
| Jul 30, 2026 | Evercore ISI Group | Maintained | In-Line | $7.50 |
| Jul 30, 2026 | Canaccord Genuity | Maintained | Buy | $10.00 |
| Jul 21, 2026 | Canaccord Genuity | Maintained | Buy | $11.00 |
| Jul 7, 2026 | B of A Securities | Maintained | Buy | $10.50 |
| May 5, 2026 | Citigroup | Maintained | Neutral | $7.00 |
| Apr 8, 2026 | Evercore ISI Group | Maintained | In-Line | $6.00 |
| Mar 26, 2026 | Barclays | Maintained | Equal-Weight | $7.00 |
| Mar 13, 2026 | JP Morgan | Maintained | Neutral | $7.00 |
| Mar 10, 2026 | Deutsche Bank | Upgraded | Hold → Buy | $11.00 |
| Mar 3, 2026 | Oppenheimer | Maintained | Outperform | $7.00 |
| Mar 3, 2026 | Citigroup | Maintained | Neutral | $6.00 |
| Feb 26, 2026 | Stifel | Maintained | Hold | $6.00 |
| Feb 26, 2026 | Evercore ISI Group | Maintained | In-Line | $5.00 |
| Feb 26, 2026 | Wells Fargo | Maintained | Equal-Weight | $6.00 |
| Feb 26, 2026 | Piper Sandler | Maintained | Overweight | $9.00 |
| Feb 26, 2026 | BMO Capital | Maintained | Market Perform | $5.00 |
| Feb 26, 2026 | TD Cowen | Maintained | Hold | $6.00 |
| Feb 26, 2026 | Leerink Partners | Maintained | Market Perform | $5.50 |
| Feb 26, 2026 | Canaccord Genuity | Maintained | Buy | $10.00 |

## Frequently Asked Questions

### What is the price target for TDOC stock?

The average 12-month analyst price target for Teladoc Health (TDOC) is $8.33, with a high estimate of $10.00 and a low of $7.50, across 3 analysts.

### Is TDOC a buy, sell, or hold?

Analysts covering Teladoc Health currently average a Hold rating: 5 buy, 19 hold and 0 sell, from 24 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for TDOC?

The average price target of $8.33 implies 39.59% upside from the last price of $5.97.

### What is the latest analyst rating on TDOC?

On Aug 3, 2026, Citigroup maintained Teladoc Health at Neutral with a price target of $7.50.

## Similar Stocks

- [AMZN](https://www.lighthorse.io/tickers/amzn) — Amazon.com, Inc. - Common Stock
- [AMWL](https://www.lighthorse.io/tickers/amwl) — American Well Corporation Class A Common Stock
- [ZM](https://www.lighthorse.io/tickers/zm) — Zoom Communications, Inc. - Class A Common Stock
- [ROKU](https://www.lighthorse.io/tickers/roku) — Roku, Inc. - Class A Common Stock
- [CRSP](https://www.lighthorse.io/tickers/crsp) — CRISPR Therapeutics AG - Common Shares
- [DOCS](https://www.lighthorse.io/tickers/docs) — Doximity, Inc. Class A Common Stock
- [PINS](https://www.lighthorse.io/tickers/pins) — Pinterest, Inc. Class A Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).